PhRMA Credits Drug Industry With 2.7 Mil. U.S. Jobs
This article was originally published in The Pink Sheet Daily
Executive Summary
Study commissioned by the trade association finds that “multiplicative” effects of every biopharmaceutical job lead to 5.7 other jobs. Industry’s weight in domestic job creation underscores the need to avoid drug price controls and importation proposals, PhRMA argues.
You may also be interested in...
J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed
Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.
J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed
Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.
Rx “Tax Holiday” Nears President’s Desk Following House Passage
A tax change that would allow U.S. pharmaceutical companies to pay a far lower duty to "repatriate" up to $500 mil. claimed by overseas affiliates remains en route to becoming law, despite objections raised by the Bush Administration